BioNTech

News

Pfizer starts dosing patients with its Omicron COVID shot

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant.

News

Japan approves Pfizer COVID vaccine for children aged 5 to 1...

Japan's health ministry has authorised the use of Pfizer and BioNTech COVID-19 vaccine in children aged between five and 11.

News

BioNTech, InstaDeep showcase early warning system for COVID ...

BioNTech and artificial intelligence start-up InstaDeep say they have developed an early warning system that can predict high-risk variants of COVID-19 from their genetic sequences much ear

R&D

Beyond the pandemic: the potential of mRNA technology

The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease.

News

Talking vaccines: Industry’s role in protecting the Gavi generation

FDA clears Pfizer, BioNTech COVID booster for younger teens

The FDA has authorised the first COVID-19 booster vaccine for teenagers in the 12 to 15 age group, giving the okay for wider use of Pfizer and BioNTech's Comirnaty shot as it tries to keep

News